These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24815844)

  • 1. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.
    Verim L; Timirci-Kahraman O; Akbulut H; Akbas A; Ozturk T; Turan S; Yaylim I; Ergen A; Ozturk O; Isbir T
    In Vivo; 2014; 28(3):397-402. PubMed ID: 24815844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FASL polymorphism is associated with response to bacillus Calmette-Guérin immunotherapy in bladder cancer.
    Lima L; Ferreira JA; Tavares A; Oliveira D; Morais A; Videira PA; Medeiros R; Santos L
    Urol Oncol; 2014 Jan; 32(1):44.e1-7. PubMed ID: 23948181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in promoter region of FAS and FASL gene and risk of cardia gastric adenocarcinoma.
    Zhou RM; Wang N; Chen ZF; Duan YN; Sun DL; Li Y
    J Gastroenterol Hepatol; 2010 Mar; 25(3):555-61. PubMed ID: 20074157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between FAS and FASL genetic variants and risk of primary brain tumor.
    Dalan AB; Timirci-Kahraman O; Turan S; Kafadar AM; Yaylim I; Ergen A; Gormus U; Gulec-Yilmaz S; Kaspar C; Isbir T
    Int J Neurosci; 2014 Jun; 124(6):443-9. PubMed ID: 24094130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of death pathway genes FAS and FASL and risk of nasopharyngeal carcinoma.
    Cao Y; Miao XP; Huang MY; Deng L; Lin DX; Zeng YX; Shao JY
    Mol Carcinog; 2010 Nov; 49(11):944-50. PubMed ID: 20842669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer.
    Zhang B; Sun T; Xue L; Han X; Zhang B; Lu N; Shi Y; Tan W; Zhou Y; Zhao D; Zhang X; Guo Y; Lin D
    Carcinogenesis; 2007 May; 28(5):1067-73. PubMed ID: 17183065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fas/FasL promoter gene polymorphism in patients with rheumatoid arthritis.
    Kobak Ş; Berdeli A
    Reumatismo; 2012 Dec; 64(6):374-9. PubMed ID: 23285481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
    Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
    Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.
    Zamani AG; Barlas IO; Durakbasi-Dursun G; Ural O; Erdal E; Yildirim MS
    Int J Immunogenet; 2013 Dec; 40(6):482-7. PubMed ID: 23560484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants in the tumor necrosis factor-related apoptosis-inducing ligand and death receptor genes contribute to susceptibility to bladder cancer.
    Timirci-Kahraman O; Ozkan NE; Turan S; Farooqi AA; Verim L; Ozturk T; Inal-Gultekin G; Isbir T; Ozturk O; Yaylim I
    Genet Test Mol Biomarkers; 2015 Jun; 19(6):309-15. PubMed ID: 25955868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional polymorphisms in FAS/FASL system contribute to the risk of occurrence but not progression of gastric cardiac adenocarcinoma.
    Zhang W; Li C; Wang J; He C
    Hepatogastroenterology; 2012; 59(113):141-6. PubMed ID: 21940365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population.
    Erdogan M; Karadeniz M; Berdeli A; Tamsel S; Ertan Y; Uluer H; Yilmaz C; Tuzun M; Kabalak T; Ozgen AG
    J Endocrinol Invest; 2007 May; 30(5):411-6. PubMed ID: 17598974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fas/FasL gene polymorphism in patients with Hashimoto's thyroiditis in Turkish population.
    Erdogan M; Kulaksizoglu M; Ganidagli S; Berdeli A
    J Endocrinol Invest; 2017 Jan; 40(1):77-82. PubMed ID: 27572459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer.
    Zhang X; Miao X; Sun T; Tan W; Qu S; Xiong P; Zhou Y; Lin D
    J Med Genet; 2005 Jun; 42(6):479-84. PubMed ID: 15937082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional variants in cell death pathway genes and risk of pancreatic cancer.
    Yang M; Sun T; Wang L; Yu D; Zhang X; Miao X; Liu J; Zhao D; Li H; Tan W; Lin D
    Clin Cancer Res; 2008 May; 14(10):3230-6. PubMed ID: 18483392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer].
    Yang S; Miao XP; Zhang XM; Sun T; Qu SN; Xiong P; Ye YJ; Guo YL; Tan W; Wang S; Lin DX
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2132-5. PubMed ID: 16313826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.
    Daripally S; Nallapalle SR; Katta S; Prasad VV
    Tumour Biol; 2015 Sep; 36(10):7817-30. PubMed ID: 25944167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
    Hsu PI; Lu PJ; Wang EM; Ger LP; Lo GH; Tsay FW; Chen TA; Yang HB; Chen HC; Lin WS; Lai KH
    Anticancer Res; 2008; 28(1A):97-103. PubMed ID: 18383830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in the apoptosis-associated genes FAS and FASL and risk of oral cancer and malignant potential of oral premalignant lesions in a Taiwanese population.
    Wang LH; Ting SC; Chen CH; Tsai CC; Lung O; Liu TC; Lee CW; Wang YY; Tsai CL; Lin YC
    J Oral Pathol Med; 2010 Feb; 39(2):155-61. PubMed ID: 20359312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fas-1377A/G and FasL-844 T/C gene polymorphisms and epithelial ovarian cancer.
    Gormus U; Ergen A; Yilmaz H; Dalan B; Berkman S; Isbir T
    Anticancer Res; 2007; 27(2):991-4. PubMed ID: 17465232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.